Autoimmune Polyendocrine Syndrome Type 1
Autoimmune Polyendocrine Syndrome Type 1 (APS-1), also known as Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED), is a rare genetic disorder characterized by the malfunction of the immune system, leading to the attack of the body's own tissues and organs. This condition is one of the types of autoimmune polyendocrine syndromes, which are a group of disorders that affect the endocrine glands.
Etiology[edit | edit source]
APS-1 is caused by mutations in the AIRE gene, which is responsible for producing a protein that plays a crucial role in the immune system. This protein helps the immune system to distinguish the body's own proteins from those made by foreign invaders such as viruses and bacteria. Mutations in the AIRE gene disrupt this function, leading to the immune system attacking the body's own cells, particularly the endocrine glands.
Symptoms[edit | edit source]
The symptoms of APS-1 vary widely among affected individuals, but they typically include chronic mucocutaneous candidiasis, hypoparathyroidism, and Addison's disease. Other symptoms may include alopecia, vitiligo, keratopathy, and dental enamel hypoplasia. The onset of symptoms usually occurs in childhood or adolescence.
Diagnosis[edit | edit source]
Diagnosis of APS-1 is based on clinical findings and genetic testing. The presence of at least two of the three major symptoms (chronic mucocutaneous candidiasis, hypoparathyroidism, and Addison's disease) is usually sufficient for a clinical diagnosis. Genetic testing can confirm the diagnosis by identifying mutations in the AIRE gene.
Treatment[edit | edit source]
Treatment for APS-1 is primarily symptomatic and supportive. It often involves hormone replacement therapy to compensate for the hormones that the affected endocrine glands are unable to produce. Regular follow-up care is necessary to monitor the patient's condition and adjust treatment as needed.
Prognosis[edit | edit source]
The prognosis for individuals with APS-1 varies depending on the severity of the symptoms and the individual's response to treatment. With appropriate management, most individuals with APS-1 can lead normal lives.
See also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD